In all, in accordance with our in vitro study, these data suggest that mutant p53 expression in human CRC tumors positively correlates with an elevated expression of ALDH and CD44, bona fide CSCs markers, which might explain the higher disease aggressiveness. The gene discussed is CD44; the disease is colorectal carcinoma.